[HTML][HTML] Long-term neurologic outcomes of COVID-19

E Xu, Y Xie, Z Al-Aly - Nature medicine, 2022 - nature.com
The neurologic manifestations of acute COVID-19 are well characterized, but a
comprehensive evaluation of postacute neurologic sequelae at 1 year has not been …

Long-term neurologic outcomes of COVID-19.

E Xu, Y Xie, Z Al-Aly - 2022 - cabidigitallibrary.org
The neurologic manifestations of acute COVID-19 are well characterized, but a
comprehensive evaluation of postacute neurologic sequelae at 1 year has not been …

Long-term neurologic outcomes of COVID-19

E Xu, Y Xie, Z Al-Aly - Nature medicine, 2022 - profiles.wustl.edu
The neurologic manifestations of acute COVID-19 are well characterized, but a
comprehensive evaluation of postacute neurologic sequelae at 1 year has not been …

Long-term neurologic outcomes of COVID-19

E Xu, Y Xie, Z Al-Aly - Nature medicine, 2022 - pubmed.ncbi.nlm.nih.gov
The neurologic manifestations of acute COVID-19 are well characterized, but a
comprehensive evaluation of postacute neurologic sequelae at 1 year has not been …

Long-term neurologic outcomes of COVID-19

E Xu, Y Xie, Z Al-Aly - Nature Medicine, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The neurologic manifestations of acute COVID-
19 are well characterized, but a comprehensive evaluation of postacute neurologic …

Long-term neurologic outcomes of COVID-19

E Xu, Y Xie, Z Al-Aly - 2022 - digitalcommons.wustl.edu
Results There were 154,068, 5,638,795 and 5,859,621 participants in the COVID-19, the
contemporary control and the historical control groups, respectively (Fig. 1). Median follow …

[HTML][HTML] Long-term neurologic outcomes of COVID-19

E Xu, Y Xie, Z Al-Aly - Nature Medicine, 2022 - ncbi.nlm.nih.gov
The neurologic manifestations of acute COVID-19 are well characterized, but a
comprehensive evaluation of postacute neurologic sequelae at 1 year has not been …